{"id":"b7h4","name":"B7-H4 (VTCN1)","symbol":"VTCN1","route":"/targets/b7h4/","asOf":"2026-09-22","xrefs":[{"hgnc":"https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:28873","ensembl":"https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000134258","uniprot":"https://www.uniprot.org/uniprotkb/Q7Z7D3/entry","alphafold-db":"https://alphafold.ebi.ac.uk/entry/Q7Z7D3","open-targets":"https://platform.opentargets.org/target/ENSG00000134258","civic":"https://civicdb.org/genes/79679/summary","oncokb":"https://www.oncokb.org/gene/VTCN1","cosmic":"https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=VTCN1","cbioportal":"https://www.cbioportal.org/results/mutations?cancer_study_list=msk_impact_2017&gene_list=VTCN1","depmap":"https://depmap.org/portal/gene/VTCN1?tab=overview","human-protein-atlas":"https://www.proteinatlas.org/ENSG00000134258-VTCN1","ncbi-gene":"https://www.ncbi.nlm.nih.gov/gene/79679","omim":"https://www.omim.org/entry/608162"}],"products":[{"id":"hs-20089","name":"HS-20089","status":"phase-3","modality":"ADC","route":"/drugs/hs-20089/"},{"id":"puxitatug-samrotecan","name":"Puxitatug samrotecan","status":"phase-2","modality":"ADC","route":"/drugs/puxitatug-samrotecan/"}],"trials":[{"id":"nct06855069","name":"HS-20089 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer","nct":"NCT06855069","phase":"3","status":"recruiting"},{"id":"nct07044336","name":"Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)","nct":"NCT07044336","phase":"3","status":"recruiting"},{"id":"nct06014190","name":"HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer","nct":"NCT06014190","phase":"2","status":"recruiting"},{"id":"nct05123482","name":"A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies","nct":"NCT05123482","phase":"1/2","status":"recruiting"}],"pathways":[],"companies":["astrazeneca","hansoh-pharma"],"keyPapers":["paper-gruosso-tnbc-spatial-immune-microenvironments-jci-2019","paper-burstein-tnbc-genomic-subtypes-ccr-2015"],"hotspots":[],"openQuestions":[],"assays":[],"resistance":[],"licence":"CC BY-NC 4.0, attribution to OnCo (https://onco.cc); commercial use needs a licence"}